Rich66
10-04-2010, 10:00 AM
http://www.fiercebiotech.com/story/cancer-researchers-testing-radical-change-drug-trials/2010-10-04?utm_medium=nl&utm_source=internal
UC San Francisco's Laura Esserman is taking a leading role in I-Spy 2, an innovative cancer trial that will rotate through up to 12 experimental cancer therapies in an effort to determine if a radical new approach can identify the right population for the right therapy on a much smaller budget.
UC San Francisco's Laura Esserman is taking a leading role in I-Spy 2, an innovative cancer trial that will rotate through up to 12 experimental cancer therapies in an effort to determine if a radical new approach can identify the right population for the right therapy on a much smaller budget.